Potent synthetic substances, new drug mixtures and changing patterns of use pose growing threat in Europe

Potent synthetic substances, new drug mixtures and changing patterns of use pose a growing threat in Europe. These are among the issues raised today by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) as it launches its European Drug Report 2024: Trends and Developments (1). Drug availability remains high in Europe, where the market offers a diverse range of products. People who use drugs are now exposed to a wider range of psychoactive substances, often of high potency or purity, or in new forms, mixtures and combinations. With products sometimes mis-sold, consumers may…